Puma Biotechnology | الأصول



Assets تغيير تاريخ
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Daiichi Sankyo JPY 3.46T 12.51B 2025-03
Exelixis USD 2.84B 110.44M 2025-04
Gilead Sciences USD 56.43B 2.56B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Incyte USD 5.75B 305.04M 2025-03
MacroGenics USD 261.65M 2.84M 2024-12
Moderna USD 12.7B 1.44B 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
PTC Therapeutics USD 2.66B 950.36M 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Takeda JPY 14.25T 858.5B 2025-03
TG Therapeutics USD 577.69M 8.32M 2024-12
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Puma Biotechnology الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.